MediciNova Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | -975.9% | – | – | – | – | – | – | – | – | – | – | |
| – | +51.6% | -1,680.5% | – | – | -11.7% | -28.1% | -50.6% | -61.3% | +66.1% | +44.5% | -60.0% | -33.5% | -47.1% | +98.9% | -7.9% | -7.5% | -10.9% | +22.5% | -32.3% | +14.6% | +3.9% | -4.6% | |
| – | – | -98.7% | +376.0% | – | – | -25.2% | -15.6% | -31.4% | -48.3% | +71.4% | +34.7% | +23.7% | +96.1% | +12.6% | +41.5% | -35.0% | -22.8% | -45.9% | -62.6% | +10.6% | +67.7% | -30.4% | |
| – | – | – | – | – | – | – | – | – | -48.2% | +68.7% | +35.6% | +26.8% | +94.4% | +11.8% | +41.0% | -34.8% | -22.8% | -45.9% | -55.5% | – | – | – | |
| – | +55.8% | +699.3% | -106.0% | – | -526.4% | – | -196.9% | – | -139.0% | – | – | -104.7% | – | -187.7% | – | – | – | – | – | -66.5% | -974.7% | – | |
| – | +2,948.6% | +204.6% | -78.6% | +82.2% | -100.0% | – | +12.8% | -67.2% | +1,270.2% | -50.2% | -91.5% | -34.1% | +3,541.5% | -87.9% | +0.0% | +10.5% | +223.7% | -21.3% | -82.6% | +325.1% | -95.8% | +223.9% | |
| – | +938.9% | +705.2% | – | +651.1% | -50.6% | -105.3% | – | -100.0% | +12,445.2% | -95.2% | -90.4% | -34.1% | +3,541.5% | +99,900.0% | – | -101.8% | +223.7% | -21.3% | +139,135.0% | – | -100.0% | +315.9% | |
| – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -94.9% | +2,393.3% | – | – | -5.5% | -100.0% | -78.0% | +712,160.0% | -77.2% | -68.9% | +322.0% | -99.5% | -11.9% | -34.0% | -46.4% | -803.3% | -41.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +494.4% | +87.4% | -101.0% | – | -99.2% | +20,763.2% | -105.1% | – | +892.7% | +765.3% | -68.9% | +322.0% | -50.7% | +24.6% | +296.5% | -75.2% | -33.1% | +192.4% | -100.0% | +409,866,756.7% | -100.0% | – | |
| – | +1,067.8% | -103.3% | – | – | -95.0% | -110.7% | – | -246.0% | – | – | +84.7% | +109.4% | -80.4% | +89.8% | +786.0% | -95.7% | -353.9% | – | -564.5% | – | -132.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -980.0% | – | – | – | – | – | – | – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.